tirzepatide cancer Scientists have discovered that tirzepatide—an FDA-approved drug for diabetes and weight loss (Mounjaro, Zepbound)—can also shrink breast tumors in obese mice. Presented at ENDO 2025, the University of Michigan study showed Investigating FDA Reports of Tirzepatide-Thyroid

While researchers are still gathering data about the weight loss benefits of both drugs, Tirzepatide is likely a more effective weight loss injection for some people

503B outsourcing facilities are ideal for large-scale, standardized sterile compounding used in hospitals, clinics, and surgery centers

Vive Ageless

Safety Considerations Common Side Effects Nausea, vomiting, diarrhea, decreased appetite, constipation, and abdominal pain Injection site reactions (redness, itching, swelling) Hypoglycemia (especially if used with insulin or sulfonylureas) Serious Risks Pancreatitis: Seek immediate medical attention for severe abdominal pain